Insider Shareholders with Direct Ownership of Better Therapeutics, Inc. (BTTX)
This section provides a comprehensive overview of the insiders with direct ownership of Better Therapeutics, Inc. (BTTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Better Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David P Perry
Executive Chairman |
2,416,634 | 0 | 2,416,634 $24,166 | 12 |
Feb 09, 2024
Added 25.79%
|
|
Mountain Crest Capital Llc
> 10% Shareholder |
142,500 | 200,000 | 1,374,000 $13,740 | 3 |
Apr 07, 2021
Reduced 12.71%
|
| 1,031,805 | 0 | 1,031,805 $10,318 | 5 |
Dec 18, 2023
Added 0.36%
|
|
|
Frank Karbe
Chief Executive Officer |
491,929 | 0 | 526,516 $5,265 | 4 |
Dec 18, 2023
Added 10.61%
|
|
Mark A. Berman
Chief Medical Officer |
181,614 | 0 | 448,140 $4,481 | 3 |
Dec 18, 2023
Added 5.36%
|
|
Kristin Wynholds
Chief Product Officer |
135,616 | 0 | 225,631 $2,256 | 4 |
Dec 18, 2023
Added 10.1%
|
| 157,369 | 0 | 157,369 $1,573 | 2 |
Dec 18, 2023
Added 2.33%
|
|
|
Mark Heinen
Chief Financial Officer |
139,723 | 0 | 139,723 $1,397 | 10 |
Apr 05, 2023
Added 27.87%
|
| 39,601 | 0 | 39,601 $396 | 4 |
Dec 18, 2023
Added 8.65%
|
|
|
Justin Zamirowski
Chief Commercial Officer |
36,913 | 0 | 36,913 $369 | 2 |
May 27, 2022
Added 4.35%
|
|
Leslie A. Miller
Principal Accounting Officer |
3,587 | 0 | 17,937 $179 | 1 |
Dec 18, 2023
Added 16.67%
|
| 17,084 | 0 | 17,084 $170 | 2 |
Dec 18, 2023
Added 18.0%
|
|
| 13,750 | 0 | 13,750 $137 | 2 |
Dec 18, 2023
Added 21.43%
|
|
|
Kevin J Appelbaum
Chief Executive Officer |
6,250 | 0 | 6,250 $62 | 6 |
Mar 31, 2022
Added 28.57%
|